A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients
一项随机、双盲、安慰剂对照研究，旨在评估BCc1纳米药物对转移性和非转移性胃癌患者生存期和生活质量的影响。
期刊:Journal of Nanobiotechnology
影响因子:12.6
doi:10.1186/s12951-019-0484-0
Hafizi, Maryam; Kalanaky, Somayeh; Moaiery, Hassan; Khayamzadeh, Maryam; Noorian, Sajad; Kaveh, Vahid; Gharib, Behrooz; Foudazi, Hossein; Razavi, Mohsen; Jenabian, Arash; Salimi, Saeid; Sereshki, Mohammad Mahdi Adib; Mirzaei, Hamid Reza; Zarghi, Afshin; Fakharzadeh, Saideh; Nazaran, Mohammad Hassan; Akbari, Mohammad Esmaeil
